Mangoceuticals, Common Stock Stock Price on October 22, 2024
| MGRX Stock | 2.53 0.05 2.02% |
If you're considering investing in Mangoceuticals, Stock, it is important to understand the factors that can impact its price. As of today, the current price of Mangoceuticals, Common stands at 2.53, as last reported on the 27th of November, with the highest price reaching 2.60 and the lowest price hitting 2.45 during the day. Mangoceuticals, Common has Sharpe Ratio of -0.0334, which conveys that the firm had a -0.0334% return per unit of risk over the last 3 months. Mangoceuticals, Common exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mangoceuticals, Common's Standard Deviation of 6.16, risk adjusted performance of (0.05), and Mean Deviation of 4.35 to check out the risk estimate we provide.
Other Stockholder Equity is likely to rise to about 12.6 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 503.1 K in 2024. . At this time, Mangoceuticals, Common's Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 8.03 in 2024, whereas Price To Sales Ratio is likely to drop 7.70 in 2024. Mangoceuticals, Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Mangoceuticals, |
Sharpe Ratio = -0.0334
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MGRX |
Estimated Market Risk
| 5.96 actual daily | 53 53% of assets are less volatile |
Expected Return
| -0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Mangoceuticals, Common is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mangoceuticals, Common by adding Mangoceuticals, Common to a well-diversified portfolio.
Price Book 0.4615 | Enterprise Value Ebitda (0.51) | Price Sales 7.1283 | Shares Float 1.4 M | Earnings Share (5.70) |
Mangoceuticals, Common Main Headline on 22nd of October 2024
Mangoceuticals Enters 150,000 Promissory Note Agreement with... by thelincolnianonline.com
On October 18, 2024, Mangoceuticals, Inc. finalized a significant financial agreement through a promissory note with Cohen Enterprises, Inc. The note, termed as the Cohen Note, outlines a 150,000 principal sum to be repaid to Cohen Enterprises, owned by Jacob D. Cohen, the Chairman and CEO of Mangoceuticals. This note encompasses two previous loans,
Mangoceuticals, Common Valuation on October 22, 2024
It is possible to determine the worth of Mangoceuticals, Common on a given historical date. On October 22, 2024 Mangoceuticals, was worth 2.35 at the beginning of the trading date compared to the closed value of 2.51. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Mangoceuticals, Common stock. Still, in general, we apply an absolute valuation method to find Mangoceuticals, Common's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Mangoceuticals, Common where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Mangoceuticals, Common's related companies.
| Open | High | Low | Close | Volume | |
| 2.45 | 2.45 | 2.20 | 2.43 | 489,692 | |
10/22/2024 | 2.35 | 2.53 | 2.34 | 2.51 | 275,529 |
| 2.41 | 2.49 | 2.32 | 2.37 | 182,609 |
| Backtest Mangoceuticals, Common | | | Mangoceuticals, Common History | | | Mangoceuticals, Common Valuation | Previous | Next |
Mangoceuticals, Common Trading Date Momentum on October 22, 2024
| On October 23 2024 Mangoceuticals, Common Stock was traded for 2.37 at the closing time. The top price for the day was 2.49 and the lowest listed price was 2.32 . The trading volume for the day was 182.6 K. The trading history from October 23, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 5.58% . The trading delta at closing time against the current closing price is 5.98% . |
Mangoceuticals, Common Fundamentals Correlations and Trends
By evaluating Mangoceuticals, Common's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Mangoceuticals, Common's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Mangoceuticals, financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Mangoceuticals, Common Stock history
Mangoceuticals, Common investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Mangoceuticals, is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Mangoceuticals, Common will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Mangoceuticals, Common stock prices may prove useful in developing a viable investing in Mangoceuticals, Common
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.4 M | 1.4 M | |
| Net Loss | -1.8 M | -1.7 M |
Mangoceuticals, Common Stock Technical Analysis
Mangoceuticals, Common technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Mangoceuticals, Common Period Price Range
Low | November 27, 2024
| High |
0.00 | 0.00 |
Mangoceuticals, Common Stock cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Mangoceuticals, Common November 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Mangoceuticals, Common stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mangoceuticals, Common shares will generate the highest return on investment. By undertsting and applying Mangoceuticals, Common stock market strength indicators, traders can identify Mangoceuticals, Common Stock entry and exit signals to maximize returns
Mangoceuticals, Common Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Mangoceuticals, Common's price direction in advance. Along with the technical and fundamental analysis of Mangoceuticals, Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Mangoceuticals, to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.53) | |||
| Total Risk Alpha | (1.48) | |||
| Treynor Ratio | (3.77) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Mangoceuticals, Stock Analysis
When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.